HAYWARD,
Calif., July 2, 2024 /PRNewswire/ -- Endiatx, a
pioneering Silicon Valley medical technology company, is shaping
the future of medicine with groundbreaking micro-robotics inside
the human body. The company's flagship innovation, PillBot™, is
designed to wirelessly navigate the human stomach, lowering costs
and increasing access to diagnosis and treatments.
Swallow a micro-robot? See PillBot™ in a
TED talk and video by Adam Savage
(of Mythbusters, The Matrix, and Star Wars).
Would you swallow a micro-robot? To many, it
seems like something straight out of science fiction. However, at
the TED and Amazon MARS conferences, Endiatx Co-Founder Dr.
Vivek Kumbhari, live on stage,
navigated PillBot™ through the stomach of Endiatx Chairman
Alex Luebke. Kumbhari, who chairs
Gastroenterology at the Mayo Clinic, described how PillBot™'s
simple means of investigating the stomach will greatly improve
medical care.
The PillBot™ micro-robot, about the size of a
vitamin pill, transmits live video as it motors throughout the
water-filled stomach. After skipping a meal, a patient drinks water
and swallows PillBot™. The physician operator – who can be remote,
with the patient at home – then maneuvers the capsule via a
controller and internet connection to scan the whole stomach.
See PillBot™ showcased in an engaging TED talk
and video by Adam Savage (of
Mythbusters, The Matrix, and Star Wars fame).
PillBot™ will complete its clinical trials later
in 2024, and Endiatx expects the device to gain FDA clearance in
2025. PillBot™ should launch commercially in the US in early 2026
and from there expand internationally – especially to developing
nations that lack access to medical facilities.
Since four out of five upper endoscopies do not
detect anything, PillBot™ will save many patients the discomfort of
sedation and a hospital visit, plus provide payers with a much more
economical cost. At the same time, PillBot™ will steer limited
hospital infrastructure and resources toward the fraction of cases
where an initial PillBot™ screening has deemed a full upper
endoscopy necessary.
With future AI-enabled movement, automation, and
diagnostics, PillBot will become even more efficient, enabling
systematic screening plus acute care. Diagnostic procedures
performed by PillBot™ and its AI-powered successors will identify
diseases such as stomach cancer – which claims some 800,000 lives
globally each year – early enough to intervene and save lives.
Endiatx, a team of 20, has raised $7 million since its 2019 founding.
For media inquiries, see the Press Page of the
Endiatx website. Join Endiatx on the journey to bring
micro-robotics inside the human body.
View original
content:https://www.prnewswire.com/news-releases/pillbot-micro-robotics-now-inside-the-human-body-302187755.html
SOURCE Endiatx